Enzyme-Linked Immunosorbent Assay Method Application in the Study of Comparative Pharmacokinetics of Insulin Glargin Preparations

por L. N. Shitov, Yu. A. Dzhurko, R. V. Drai, I. E. Makarenko, A. L. Khokhlov, L. A. Khozova, O. V. Afonkina, Yu. A. Sevastyanova, N. A. Vasilenko, A. A. Abramova
Publicado 2019

On the safety of insulin Glargine

por Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Valentina Alexandrovna Peterkova
Publicado 2009

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus

por Lau IT, Lee KF, So WY, Tan K, Yeung VTF
Publicado 2017

Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study

por Nader ND, Hamishehkar H, Naghizadeh A, Shadvar K, Iranpour A, Sanaie S, Chang F, Mahmoodpoor A
Publicado 2020

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine...

por Marina Vladimirovna Shestakova, Irina Vladimirovna Glinkina
Publicado 2010

Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents

por Tamara Leonidovna Kuraeva
Publicado 2014

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

por Liu D, Bai JJ, Yao JJ, Wang YB, Chen T, Xing Q, Bai R
Publicado 2021

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland

por Thomann R, Zechmann S, Alexander-David N, Jornayvaz FR
Publicado 2020

Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring

por Huiying Wang, Yunting Zhou, Xiaofang Zhai, Bo Ding, Ting Jing, Xiaofei Su, Huiqin Li, Jianhua Ma
Publicado 2021

Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study

por Davis KL, Wei W, Meyers JL, Kilpatrick BS, Pandya N
Publicado 2014

Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect

por Vadim Valer'evich Klimontov, Natalya Evgen'evna Myakina
Publicado 2014

Evaluation of biosimilarity of RinGlar® (GEROPHARM LLC, Russia) and Lantus® (Sanofi-Aventis Deutschland GmbH, Germany) using the euglycemic hyperinsulinemic clamp technique in pati...

por Alexander Y. Mayorov, Roman V. Drai, Tatiana L. Karonova, Olga I. Avdeeva, Igor E. Makarenko, Ekaterina O. Koksharova, Ekaterina Е. Mishina, Yulia А. Sevastyanova, Olena V. Afonkina
Publicado 2020

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)

por Ivona Renata Yarek-Martynova, Lyubov' Leonidovna Bolotskaya
Publicado 2011